China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	42.95B -19.7%
Revenue (ttm)	31.81B +12.3%
Net Income	3.28B +17.7%
EPS	1.97 +17.7%
Shares Out	1.66B
PE Ratio	13.10
Forward PE	11.16
Dividend	1.04 (4.03%)
Ex-Dividend Date	May 29, 2026

Volume	12,159,974
Open	25.96
Previous Close	25.81
Day's Range	25.60 - 26.45
52-Week Range	21.60 - 32.35
Beta	-0.01
Analysts	Strong Buy
Price Target	37.64 (+43.88%)
Earnings Date	Aug 22, 2026

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 30,304
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2025, SHE:000999's revenue was 31.60 billion, an increase of 14.43% compared to the previous year's 27.62 billion. Earnings were 3.42 billion, an increase of 1.58%.

Analyst Summary

According to 11 analysts, the average rating for 000999 stock is "Strong Buy." The 12-month stock price target is ¥37.64, which is an increase of 43.88% from the latest price.

Price Target

¥37.64

(43.88% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 3, 2026

Data Sources Report a data error